Advanced search
Publication Cover
Expert Review of Ophthalmology Volume 8, 2013 - Issue 3
Submit an article Journal homepage
26
Views
0
CrossRef citations to date
0
Altmetric
Meeting Report

New advances in retina: a report from the International Symposium on Ocular Pharmacology and Therapeutics meeting

Daniele Veritti Department of Ophthalmology, University of Udine, Udine, Italy; IEMO – Istituto Europeo di Microchirurgia Oculare, Udine, Italy; Department of Ophthalmology, University of Udine, Udine, Italy; IEMO – Istituto Europeo di Microchirurgia Oculare, Udine, Italy
,
Valentina Sarao Department of Ophthalmology, University of Udine, Udine, Italy; Department of Ophthalmology, University of Udine, Udine, Italy
&
Paolo Lanzetta Department of Ophthalmology, University of Udine, Udine, Italy. [email protected]; IEMO – Istituto Europeo di Microchirurgia Oculare, Udine, Italy; Department of Ophthalmology, University of Udine, Udine, Italy. [email protected]; IEMO – Istituto Europeo di Microchirurgia Oculare, Udine, Italy
Pages 237-239 | Published online: 09 Jan 2014

References

  • Bandello F. Ranibizumab for RVO: BRAVO, CRUISE, HORIZON. Presented at: 10th International Symposium on Ocular Pharmacology and Therapeutics. Paris, France, 7–10 March 2013.
  • Veritti D, Lanzetta P. Aflibercept for central retinal vein occlusion. Presented at: 10th International Symposium on Ocular Pharmacology and Therapeutics. Paris, France, 7–10 March 2013.
  • Udaondo P. Dexamethasone implant: GENEVA trial’s everyday clinical practice. Presented at: 10th International Symposium on Ocular Pharmacology and Therapeutics. Paris, France, 7–10 March 2013.
  • Boyer D. 36 Month RISE and RIDE. Presented at: 10th International Symposium on Ocular Pharmacology and Therapeutics. Paris, France, 7–10 March 2013.
  • Udaondo P. Latest outcomes of aflibercept for DME trials. Presented at: 10th International Symposium on Ocular Pharmacology and Therapeutics. Paris, France, 7–10 March 2013.
  • Mones J. Combination therapy targeting VEGF and PDGF for wet AMD. Presented at: 10th International Symposium on Ocular Pharmacology and Therapeutics. Paris, France, 7–10 March 2013.
  • Kuppermann B. Ocriplasmin for pharmacologic treatment of vitreomacular traction (VMT): results of the MIVI-TRUST program. Presented at: 10th International Symposium on Ocular Pharmacology and Therapeutics. Paris, France, 7–10 March 2013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.